col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


47 Results       Page 1

 [1] 
Central Research Institute for Epidemiology: Problems of Virology
  original article Date Title Authors   All Authors
1 [GO] 2025―Jan―16 Pre-clinical safety studies of intranasal virus-like particles based vaccine for prevention of COVID-19 Yana Y. Chernoryzh, Valeria M. Kondratieva, Аnastasia P. Malkova, Tatyana E. Savochkina, Olesya V. Eliseeva, Oleg E. Latyshev, et al. (+4)
2 [GO] 2025―Jan―15 Retrospective analysis and forecasting of the spread of viruses in real time: the case of COVID-19 in St. Petersburg and Moscow in 2020-2021 Victor V. Zakharov, Yulia E. Balykina
3 [GO] 2024―Nov―09 Plain-nosed bats (family Vespertilionidae) as a possible reservoir of lyssaviruses and coronaviruses in Western Siberia and the south of European Russia Olesia V. Ohlopkova, Yulia V. Kononova, Marina A. Tyumentseva, Alexander I. Tyumentsev, Alexander M. Shestopalov, Vasily G. Akimkin
4 [GO] 2024―Nov―09 Evaluation of the effectiveness of chemical inactivation and immunogenicity of the Omicron variant of the SARS-CoV-2 virus Gulzhan A. Zhapparova, Balzhan S. Myrzakhmetova, Talshyngul M. Tlenchiyeva, Aiganym A. Tussipova, Karina B. Bissenbayeva, Aizhan S. Toytanova, Lespek B. Kutumbetov
5 [GO] 2024―Sep―26 The Molecular and Biological Patterns Underlying Sustained SARS-CoV-2 Circulation in the Human Population Daria D. Kustova, Andrei A. Pochtovyi, Olga G. Shpakova, Irina A. Shtinova, Nadezhda A. Kuznetsova, Denis A. Kleimenov, et al. (+2)
6 [GO] 2024―Jul―05 Immune reactivity of two biological models to vaccination with inactivated vaccine QazVac against coronavirus infection COVID-19 Balzhan Sh. Myrzakhmetova, Gulzhan A. Zhapparova, Karina B. Bisenbayeva, Aizhan S. Toytanova, Moldir S. Tuyskanova, Kuandyk D. Zhugunissov, Lespek B. Kutumbetov
7 [GO] 2024―Jul―05 Electrolytes, Zinc and Vitamin D<sub>3</sub> in COVID-19 Patients with Cardiovascular Complications Ali Abdel-Moneim Mohammed-Hussain AlKhuzaie, Enas Abdul Kareem Jabbar, Bushra Jabbar Albadry
8 [GO] 2024―Jul―05 Coronaviruses (<i>Coronaviridae</i>) of bats in the northern Caucasus and south of western Siberia Liudmila N. Yashina, Alexander V. Zhigalin, Sergey A. Abramov, Ekaterina M. Luchnikova, Natalia A. Smetannikova, Tamara A. Dupal, et al. (+5)
9 [GO] 2024―May―06 The use of immunoglobulins and monoclonal antibodies against COVID-19 Elena E. Popadyuk, Tatyana E. Sizikova, Aleksey L. Khmelev, Mikhail A. Timofeev, Vitaliy N. Lebedev, Sergey V. Borisevich
10 [GO] 2024―May―06 Detection rates and high concentration of herpesvirus (Orthoherpesviridae) DNA in autopsy materials from patients with COVID-19 fatal outcome Kirill I. Yurlov, Sofia A. Yakushina, Natalya E. Fedorova, Lidiia B. Kisteneva, Elena I. Kelly, Alexander A. Kanibolotsky, et al. (+9)
11 [GO] 2024―May―06 Development, production and characterization of SARS-CoV-2 virus-like particles (Coronaviridae: <i>Orthocoronavirinae: Betacoronavirus: Sarbecovirus</i>) Oleg E. Latyshev, Olga N. Zaykova, Olesya V. Eliseeva, Tatyana E. Savochkina, Yana Yu. Chernoryzh, Anton V. Syroeshkin, et al. (+15)
12 [GO] 2024―Mar―14 Why may the 21st century become the «century of pandemics»? А question for discussion Felix I. Ershov
13 [GO] 2023―Dec―26 Clinical symptoms and signs in hamsters during experimental infection with the SARS-CoV-2 virus (Coronaviridae: <i>Betacoronavirus</i>) Moldir S. Tuyskanova, Kuandyk D. Zhugunissov, Mehmet Ozaslan, Balzhan S. Myrzakhmetova, Lespek B. Kutumbetov
14 [GO] 2023―Nov―07 Association of polymorphic variants of hemostatic system genes with the course of COVID-19 Lyudmila I. Nikolaeva, Maya D. Stuchinskaya, Anna V. Dedova, Shevchenko G. Nadezhda, Irina N. Khlopova, Irina S. Kruzhkova, et al. (+14)
15 [GO] 2023―Jul―06 Intranasal vaccine against COVID-19 based on a recombinant variant of the Sendai virus (Paramyxoviridae: <i>Respirovirus</i>) strain Moscow Gleb A. Kudrov, Sergei S. Zainutdinov, Antonina A. Grazhdantseva, Andrey V. Shipovalov, Galina F. Sivolobova, Anastasiya V. Semenova, et al. (+7)
16 [GO] 2023―Jul―06 Development and preservation of specific T-cell immunity after COVID-19 or vaccination against this infection Mariya S. Blyakher, Irina M. Fedorova, Elena A. Tulskaya, Ivan V. Kapustin, Svetlana I. Koteleva, Zarema K. Ramazanova, et al. (+5)
17 [GO] 2023―Jul―06 Predictive role of erythrocytes in assessment of COVID-19 outcomes Yuri N. Smolyakov, Boris I. Kuznik, Elena V. Fefelova, Lyudmila S. Kazantseva, Yuri K. Shapovalov, Maria S. Lukyanchuk, et al. (+2)
18 [GO] 2023―May―18 Evaluation of the dynamics of detection of viable SARS-CoV-2 (Coronaviridae: <i>Betacoronavirus: Sarbecovirus</i>) in biological samples obtained from patients with COVID-19 in a health care setting, as one of the indicators of the infectivity of the virus Nadezhda A. Kuznetsova, Darya A. Ogarkova, Vladimir A. Gushchin, Natalya А. Antipyat, Valeria V. Bacalin, Olga A. Burgasova, et al. (+14)
19 [GO] 2023―Feb―07 Assesment of specific T-cell immunity to SARS-CoV-2 virus antigens in COVID-19 reconvalescents Maria S. Blyakher, Irina M. Fedorova, Elena A. Tulskaya, Ivan V. Kapustin, Svetlana I. Koteleva, Zarema K. Ramazanova, et al. (+3)
20 [GO] 2023―Feb―07 Genetic diversity of Siberian bovine coronavirus isolates (Coronaviridae: Coronavirinae: <i>Betacoronavirus-1: Bovine-Like coronaviruses</i>) Alexander G. Glotov, Aleksej V. Nefedchenko, Anton G. Yuzhakov, Svetlana V. Koteneva, Tatyana I. Glotova, Alina K. Komina, Nikita Yu. Krasnikov
21 [GO] 2023―Feb―07 Molecular epidemiological analysis of SARS-CoV-2 genovariants in Moscow and Moscow region Ekaterina N. Ozhmegova, Tatyana E. Savochkina, Alexey G. Prilipov, E. .E. Tikhomirov, Victor F. Larichev, Mukhammad A. Sayfullin, Tatyana V. Grebennikova
22 [GO] 2022―Dec―03 An electron microscopic study of neocortex of Syrian hamsters (<i>Mesocricetus auratus</i>) infected with SARS-CoV-2 (Coronaviridae: <i>Coronavirinae: Betacoronavirus: Sarbecovirus</i>) Natal’ya M. Paramonova, Sergey V. Chepur, Mariya О. Pervak, Vadim A. Myasnikov, Mikhail A. Tyunin, Nikita S. Ilinskiy, et al. (+2)
23 [GO] 2022―Dec―03 Comparative study of Wuhan-like and omicron-like variants of SARS-CoV-2 in experimental animal models Irina A. Leneva, Daria I. Smirnova, Nadezhda P. Kartashova, Anastasiia V. Gracheva, Anna V. Ivanina, Ekaterina A. Glubokova, et al. (+7)
24 [GO] 2022―May―06 Biological activity of interferons in the novel coronavirus infection COVID-19 T. P. Ospelnikova, D. S. Levitskaya, L. V. Kolodyazhnaya, A. D. Shitova, V. N. Osiptsov, L. R. Arifullina, et al. (+7)
25 [GO] 2022―May―06 The problem of the use of interferons in the novel coronavirus disease COVID-19 (Coronaviridae: Coronavirinae: Betacoronavirus: Sarbecovirus) F. I. Ershov, A. N. Narovlyansky
26 [GO] 2022―May―06 Bromhexine is a potential drug for COVID-19; From hypothesis to clinical trials S. Bahadoram, B. Keikhaei, M. Bahadoram, M.-R. Mahmoudian-Sani, S. Hassanzadeh, A. Saeedi-Boroujeni, K. Alikhani
27 [GO] 2022―Mar―16 Detection SARS-CoV-2 (<i>Coronaviridae: Coronavirinae: Betacoronavirus: Sarbecovirus</i>) in children with acute intestinal infection in Nizhny Novgorod during 2020-2021 O. V. Morozova, N. A. Novikova, N. V. Epifanova, D. V. Novikov, V. V. Mokhonov, T. A. Sashina, N. N. Zaytseva
28 [GO] 2022―Jan―12 Molecular methods for diagnosing novel coronavirus infection: comparison of loop-mediated isothermal amplification and polymerase chain reaction V. G. Akimkin, V. V. Petrov, K. V. Krasovitov, N. I. Borisova, I. A. Kotov, E. N. Rodionova, et al. (+4)
29 [GO] 2022―Jan―12 Specific features of the pathology of the respiratory system in SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus: Sarbecovirus) infected Syrian hamsters (Mesocricetus auratus) S. V. Chepur, I. I. Alekseeva, O. O. Vladimirova, V. A. Myasnikov, M. A. Tyunin, N. S. Ilinskii, et al. (+3)
30 [GO] 2021―Sep―18 Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic A. Yu. Popova, V. S. Smirnov, E. B. Ezhlova, A. A. Mel’nikova, L. V. Samoilova, L. V. Lyalina, et al. (+5)
31 [GO] 2021―Sep―18 Potential of application of the RNA interference phenomenon in the treatment of new coronavirus infection COVID-19 E. A. Pashkov, E. R. Korchevaya, E. B. Faizuloev, O. A. Svitich, E. P. Pashkov, D. N. Nechaev, V. V. Zverev
32 [GO] 2021―Sep―18 Prospects for using low-dose radiation in the complex therapy for COVID-19 D. V. Saleeva, G. D. Zasukhina
33 [GO] 2021―Sep―18 Monitoring the spread of the SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbecovirus) variants in the Moscow region using targeted high-throughput sequencing N. I. Borisova, I. A. Kotov, A. A. Kolesnikov, V. V. Kaptelova, A. S. Speranskaya, L. Yu. Kondrasheva, et al. (+3)
34 [GO] 2021―May―15 Reactivation of Epstein-Barr virus (Herpesviridae: Lymphocryptovirus, HHV-4) infection during COVID-19: epidemiological features T. V. Solomay, T. A. Semenenko, N. N. Filatov, S. L. Vedunova, V. F. Lavrov, D. I. Smirnova, et al. (+2)
35 [GO] 2021―May―15 Susceptibility of animal species to experimental SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbecovirus) infection N. V. Petrova, K. K. Ganina, S. A. Tarasov
36 [GO] 2021―May―15 In vitro activity of human recombinant alpha-2b interferon against SARS-CoV-2 virus S. Ya. Loginova, V. N. Shсhukina, S. V. Savenko, S. V. Borisevich
37 [GO] 2021―Mar―08 Interferon gamma in the treatment of patients with moderate COVID-19 A. L. Myasnikov, S. A. Berns, P. A. Talyzin, F. I. Ershov
38 [GO] 2021―Mar―08 Effect of anticoagulant therapy on the course of COVID-19 in comorbid patients T. A. Ruzhentsova, D. A. Khavkina, P. V. Chukhliaev, A. A. Garbuzov, A. A. Ploskireva
39 [GO] 2021―Mar―08 Rapid diagnostics of novel coronavirus infection by loop-mediated isothermal amplification K. F. Khafizov, V. V. Petrov, K. V. Krasovitov, M. V. Zolkina, V. G. Akimkin
40 [GO] 2020―Nov―16 Analysis of human coronaviruses circulation S. B. Yatsyshina, M. V. Mamoshina, O. Yu. Shipulina, A. T. Podkolzin, V. G. Akimkin
41 [GO] 2020―Sep―18 Patterns of the SARS-CoV-2 epidemic spread in a megacity V. G. Akimkin, S. N. Kuzin, T. A. Semenenko, O. Yu. Shipulina, S. B. Yatsyshina, E. V. Tivanova, et al. (+10)
42 [GO] 2020―Jul―22 The use of viral RNA polymerase inhibitors in combination with a fusion inhibitor in the treatment of patients with COVID-19: hypothesis O. V. Gaisenok
43 [GO] 2020―May―17 Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus) Dmitry K. Lvov, Sergey V. Alkhovsky
44 [GO] 2020―Apr―06 Amino acid polymorphism at residue 222 of the receptor-binding site of the hemagglutinin of the pandemic influenza A(H1N1)pdm09 from patients 166 with lethal virus pneumonia in 2012-2014 K. G. Krasnoslobodtsev, D. K. Lvov, S. V. Alkhovsky, E. I. Burtseva, I. T. Fedyakina, L. V. Kolobukhina, et al. (+5)
45 [GO] 2020―Apr―06 DIAGNOSTIC CAPACITY OF DETECTION OF SPECIFIC ANTIBODIES TO PANDEMIC INFLUENZA A(H1N1)PDM09 VIRUS E. A. Mukasheva, L. I. Nikolaeva, P. I. Makhnovsky, E. S. Kirillova, L. V. Kolobukhina, L. N. Merkulova, et al. (+3)
46 [GO] 2020―Apr―06 EVOLUTION OF PANDEMIC INFLUENZA VIRUS A(H1N1)PDM09 IN 2009-2016: DYNAMICS OF RECEPTOR SPECIFICITY OF THE FIRST HEMAGGLUTININ SUBUNIT (HA1) D. K. Lvov, V. S. Bogdanova, I. M. Kirillov, M. Yu. Shchelkanov, E. I. Burtseva, N. V. Bovin, et al. (+7)
47 [GO] 2020―Mar―17 Etiology of epidemic outbreaks COVID-19 in Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak D. K. Lvov, S. V. Alkhovsky, L. V. Kolobukhina, E. I. Burtseva
 [1] 

47 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec